Rating Overview and Context
On 21 July 2025, MarketsMOJO revised its rating on TTK Healthcare Ltd. from 'Hold' to 'Sell', reflecting a significant change in the company’s overall assessment. The Mojo Score, a composite indicator of quality, valuation, financial trend, and technical factors, declined by 18 points from 55 to 37. This shift signals a more cautious stance towards the stock, advising investors to consider reducing exposure or avoiding new purchases.
It is important to note that while the rating change occurred in mid-2025, the data and analysis presented here are based on the latest available information as of 13 February 2026. This ensures that investors receive a current and comprehensive understanding of the stock’s performance and prospects.
Here’s How the Stock Looks Today
As of 13 February 2026, TTK Healthcare Ltd. remains a microcap company operating within the diversified sector. The stock has experienced a downward trend in recent months, with a one-day decline of 0.57%, a one-month drop of 4.93%, and a one-year return of -23.01%. These figures indicate sustained underperformance relative to broader market indices such as the BSE500, which the stock has lagged over one year, three months, and three years.
Quality Assessment
The company’s quality grade is currently rated as average. Over the past five years, net sales have grown at an annualised rate of 6.99%, while operating profit has expanded at a more robust 15.42% per annum. Despite this moderate growth, the company’s recent financial results have been flat, with no significant improvement in key metrics during the December 2025 half-year period.
Cash and cash equivalents stood at ₹600.89 crores, marking the lowest level in recent periods, which may raise concerns about liquidity. Additionally, the debtors turnover ratio has declined to 7.40 times, also the lowest recorded, suggesting potential inefficiencies in receivables management. Non-operating income accounted for 80.43% of profit before tax in the quarter, indicating that core business operations may be under pressure.
Valuation Perspective
From a valuation standpoint, TTK Healthcare Ltd. is currently rated as attractive. This suggests that the stock is trading at a relatively low price compared to its earnings, book value, or cash flow metrics. However, an attractive valuation alone does not guarantee positive returns, especially when other factors such as quality and financial trends are less favourable. Investors should weigh valuation against the company’s operational challenges and market sentiment.
Financial Trend Analysis
The financial grade for TTK Healthcare Ltd. is flat, reflecting stagnation in key financial indicators. The company’s growth trajectory has slowed, and recent results have not shown meaningful improvement. This flat trend is corroborated by the stock’s negative returns over multiple time frames, including a 23.01% decline over the past year. Such performance highlights the challenges the company faces in generating sustainable growth and profitability.
Technical Outlook
Technically, the stock is rated bearish. The downward momentum is evident in the recent price declines and the failure to sustain gains over short and medium-term periods. This bearish technical grade suggests that market sentiment remains weak, and the stock may continue to face selling pressure unless there is a significant change in fundamentals or broader market conditions.
Investor Implications of the 'Sell' Rating
MarketsMOJO’s 'Sell' rating on TTK Healthcare Ltd. advises investors to exercise caution. The combination of average quality, attractive valuation, flat financial trends, and bearish technicals indicates that the stock currently carries elevated risks. Investors holding the stock may consider reducing their positions to limit downside exposure, while prospective buyers should carefully evaluate whether the potential rewards justify the risks involved.
Furthermore, the limited interest from domestic mutual funds, which hold only 0.01% of the company, may reflect a lack of confidence from institutional investors who typically conduct thorough research. This small stake could signal concerns about the company’s business model or valuation at current levels.
Our current Stock of the Month is out! This Large Cap from Automobiles - Passenger Cars emerged as the single best opportunity from our elite universe. Get the details now!
- - Current monthly selection
- - Single best opportunity
- - Elite universe pick
Summary and Outlook
In summary, TTK Healthcare Ltd.’s current 'Sell' rating reflects a comprehensive evaluation of its present-day fundamentals and market performance. While the stock’s valuation appears attractive, the average quality, flat financial trends, and bearish technical indicators suggest caution. The company’s recent financial results and stock returns have not met investor expectations, and institutional interest remains minimal.
Investors should closely monitor upcoming quarterly results and any strategic initiatives by the company that could improve operational efficiency or growth prospects. Until then, the 'Sell' rating serves as a prudent guide for managing risk in portfolios containing TTK Healthcare Ltd.
Key Metrics as of 13 February 2026
Market Capitalisation: Microcap segment
Mojo Score: 37.0 (Sell)
Quality Grade: Average
Valuation Grade: Attractive
Financial Grade: Flat
Technical Grade: Bearish
Stock Returns: 1D: -0.57%, 1W: -0.32%, 1M: -4.93%, 3M: -16.76%, 6M: -17.17%, YTD: -8.69%, 1Y: -23.01%
